IHM
VKTX icon

Iguana Healthcare Management’s Viking Therapeutics VKTX Stock Holding History

Iguana Healthcare Management’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$1.64M Buy
375,000
+150,000
+67% +$830K 1.08% 39
2017
Q4 		$913K Buy
+225,000
New +$653K 0.59% 50

Other funds holding VKTX

BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

Iguana Healthcare Management's VKTX Position: Q1 2018 in Review

Iguana Healthcare Management increased its Viking Therapeutics (VKTX) stake by 67% in Q1 2018, buying an estimated $830K and bringing the position to 375,000 shares worth $1.64M. The position accounts for 1.08% of the portfolio, ranked #39.

Iguana Healthcare Management first reported a position in VKTX in Q4 2017 and has held it in 2 quarters since. 66 funds tracked by Wall St. Rank hold VKTX as of Q1 2018.

  • Iguana Healthcare Management held 375,000 shares of Viking Therapeutics worth $1.64M as of Q1 2018.
  • Iguana Healthcare Management bought 150,000 Viking Therapeutics shares in Q1 2018, an estimated $830K.
  • Viking Therapeutics made up 1.08% of Iguana Healthcare Management's portfolio in Q1 2018, its #39 holding.
  • Iguana Healthcare Management first reported a position in Viking Therapeutics in Q4 2017 and has held it in 2 quarters since.
  • 66 funds tracked by Wall St. Rank held Viking Therapeutics as of Q1 2018.

Based on Iguana Healthcare Management's 13F filing for Q1 2018, filed 15 May 2018.